Differences in psychosocial variables between unaffected relatives and probands pursuing BRCA1/2 genetic counseling

Patti Vegella(Georgetown University), Marc D. Schwartz(Guardia Civil), Marie Wood(University of Colorado Cancer Center), Tiffani A. DeMarco(Georgetown University), Sarah A. Kelleher(Icahn School of Medicine at Mount Sinai), Wendy McKinnon(University of Vermont), Claudia Amendola(University of Vermont), Scott P. Kelly(Pfizer (United States)), Kristi D. Graves(Georgetown University), Beth N. Peshkin(Georgetown University), Heiðdís Valdimarsdóttir(Reykjavík University), Rachel Nusbaum(Icahn School of Medicine at Mount Sinai)
Cancer Epidemiology and Prevention Biomarkers
December 1, 2007
Cited by 0

Related Papers

The Group-Based Medical Mistrust Scale: psychometric properties and association with breast cancer screening
|Preventive Medicine|2003|495
Founder and Recurrent CDH1 Mutations in Families With Hereditary Diffuse Gastric Cancer
|JAMA|2007|455
Second Malignant Neoplasms: Assessment and Strategies for Risk Reduction
|Journal of Clinical Oncology|2012|336
Depressive symptoms, mental wellbeing, and substance use among adolescents before and during the COVID-19 pandemic in Iceland: a longitudinal, population-based study
|The Lancet Psychiatry|2021|302
Pathogenic and likely pathogenic variant prevalence among the first 10,000 patients referred for next-generation cancer panel testing
|Genetics in Medicine|2015|292